Latest

age related macular degeneration

Featured Neuroscience Visual Neuroscience

·June 10, 2025·2 min read

Sticky Molecules May Hold the Key to Preventing Vision Loss in AMD

A new study reveals how sticky molecules called heparan sulfate (HS) may trap lipoproteins in the eye and trigger early age-related macular degeneration (AMD). These fat-protein particles, similar to HDL, accumulate between retinal layers, forming drusen that damage vision over time.

Featured Neuroscience Visual Neuroscience

·May 23, 2025·4 min read

Eye Surgery Technique Could Restore Vision in Macular Degeneration

Scientists have developed a novel surgical method allowing two retinal tissue grafts to be implanted in a single eye, advancing treatment strategies for dry age-related macular degeneration (AMD). This new approach enables side-by-side testing of grafts—one with retinal pigment epithelial (RPE) cells and one without—within the same lesion, using a specially designed clamp to maintain eye pressure and reduce damage.

Featured Neuroscience Visual Neuroscience

·April 22, 2025·4 min read

Rewiring Retinal Messages to Slow Vision Loss in AMD

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80. New research is uncovering how retinal cells communicate using microRNA and extracellular vesicles (EVs), with the goal of slowing AMD progression.

Featured Neuroscience Visual Neuroscience

·April 17, 2025·6 min read

Gold Nanoparticles Restore Vision in Macular Degeneration

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses. When activated by patterned infrared light, these nanoparticles stimulate retinal cells, bypassing damaged photoreceptors.

Featured Neuroscience Visual Neuroscience

·December 4, 2024·4 min read

Sleep Apnea May Increase Risk of Wet Macular Degeneration

A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD). The research suggests nocturnal hypoxia could affect the oxygen-sensitive retina, contributing to AMD progression.

Featured Genetics Neuroscience Visual Neuroscience

·October 2, 2024·4 min read

Targeting Protein Reduces Macular Degeneration Symptoms

New research identifies a protein, TIMP3, overproduced in age-related macular degeneration (AMD) that may drive the disease’s progression. By targeting the enzyme linked to inflammation and drusen formation, scientists reduced early signs of AMD in stem cell models, offering hope for new treatments.

Featured Genetics Neuroscience Visual Neuroscience

·September 9, 2024·4 min read

Gene Therapy Offers Hope for Glaucoma and AMD

A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss. The therapy protects retinal ganglion cells, essential for vision, and improves their function in animal models of glaucoma. It also enhances energy production in human retinal cells, which could prevent further damage. This therapy offers a new and promising approach to treating a condition that affects millions worldwide.

Featured Neuroscience Visual Neuroscience

·July 16, 2024·6 min read

Antioxidants Slow Vision Loss in Late-Stage Dry AMD

Researchers found that daily antioxidant supplements slow the progression of late-stage dry age-related macular degeneration (AMD). The supplements help preserve central vision by slowing the expansion of geographic atrophy regions in the retina. This finding supports the use of AREDS2 supplements for people with late dry AMD.

Featured Neuroscience Visual Neuroscience

·July 10, 2024·4 min read

Detecting Early Vision Loss in Macular Degeneration

A new study reveals that early changes in age-related macular degeneration (AMD) can lead to measurable local vision loss. Researchers used advanced imaging to find that iRORA lesions, early signs of retinal damage, significantly reduce visual acuity. This discovery could enhance monitoring and treatment of AMD, potentially preventing severe vision loss. The findings offer hope for earlier intervention in this progressive eye disease.

Featured Neuroscience Visual Neuroscience

·June 12, 2024·6 min read

Robot System Reduces Eye Injections for AMD Patients

Researchers successfully used a custom-built robot to treat wet age-related macular degeneration (AMD). This minimally invasive treatment reduces the need for frequent eye injections. The landmark study found that robotic radiotherapy significantly decreases the number of injections needed, potentially saving millions annually. The new method offers precise targeting of radiation to the eye, improving patient outcomes and reducing costs.

This shows an older man undergoing an eye exam.

Featured Neuroscience Visual Neuroscience

·June 5, 2024·3 min read

New Breakthrough Treatment for Age-Related Macular Degeneration

Researchers discovered that boosting the protein IRAK-M in retinal cells can effectively treat age-related macular degeneration (AMD). This revolutionary therapy offers a comprehensive approach to AMD, a leading cause of vision loss affecting 200 million people worldwide.

Featured Genetics Neuroscience Visual Neuroscience

·August 28, 2023·5 min read

New Cell Atlas Signals Hope for Aging Visual Impairments

Researchers created a groundbreaking "cell atlas" of the human eye that could revolutionize treatments for blinding diseases like glaucoma and macular degeneration. The atlas identifies nearly 160 unique cell types across different eye structures, and pinpoints which genes each cell type expresses.

1 2 3 … 5

age related macular degeneration

Ear Wax Reveals Parkinson’s Disease Biomarkers

New Genetic Link to OCD Found

How Memory and Habits Shape Mental Health Outcomes

Subscribe